🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study EBSI-CV-317-007 is a field study to evaluate the efficacy, immunogeni...
Status
Recruiting
Location
WRAIR-AFRIMS Philippines, Cebu (WRAIR-APC)
Start Date
2026-05-26
Trial ID
NCT07467707
Treatments Being Tested
Multicenter, double-blind study comparing SLI-F06 to vehicle formulation bu...
Status
Completed
Location
Site 1
Start Date
2019-03-03
Trial ID
NCT03880058
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of three ...
Status
Terminated
Location
Study Site 07
Start Date
2013-10
Trial ID
NCT01999192
Treatments Being Tested
The primary purpose of this multi-centre, double blind-study is to evaluate...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01635621
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of 2 sin...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-08
Trial ID
NCT02926430
Treatments Being Tested
This study will be an open-label superiority, multicenter, single-blind, co...
Status
Unknown
Location
University of Arizona
Start Date
2022-09-19
Trial ID
NCT05434260
Treatments Being Tested
This Phase 1 study will test the safety and immune response of the investig...
Status
Not Yet Recruiting
Location
Palm Springs Community Health Center
Start Date
2026-10-20
Trial ID
NCT07142278
Treatments Being Tested
Primary objective was to demonstrate overall survival improvement with afli...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2007-08
Trial ID
NCT00519285
Treatments Being Tested
This is a phase 1, randomized, double-blind, placebo-controlled, multiple a...
Status
Completed
Location
Chungnam National University Hospital
Start Date
2017-02-16
Trial ID
NCT03144934
The purpose of this study is to evaluate the safety, tolerability, PK, and ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07
Trial ID
NCT02481674